Introduction {#h0.0}
============

Malaria is a major health threat, with approximately 216 million cases of clinical malaria and as many as 1.24 million deaths annually ([@B1]), mostly children under five living in sub-Saharan Africa. Mechanisms of gene expression and rearrangement during various phases of parasite development in the vertebrate and invertebrate hosts and during disease and immune evasion are poorly understood. The virulence of *Plasmodium falciparum*, one of the four established parasite species causing human malaria, is thought to result, at least in part, from the way in which parasites modify antigens on the surface of infected erythrocytes ([@B2]). This phenomenon, known as antigenic variation, has implications for severe and pregnancy-associated malaria and for the development of an efficient vaccine ([@B3]). DNA recombination is thought to play a role in generating diversity within the *var* gene family.

The exchange of genetic information between allelic sequences has essential roles in eliminating deleterious lesions, such as DNA double-strand breaks (DSB), preserving replication forks for chromosome segregation during meiosis and for maintenance of genomic integrity ([@B4]). The class of enzymes that catalyze this process are known as recombinases, and their assembly on homologous DNA sequences is a rate-limiting process, mediated by a number of accessory factors ([@B5]). Eukaryotic Rad51, like its bacterial homologue RecA, is an essential protein for mitotic homologous recombination (HR) events and catalyzes the pairing and interactions between homologous DNA strands necessary for promoting single-strand exchange (SSE). Similar to *Escherichia coli* RecA protein, ScRad51 and HsRad51 in *Saccharomyces cerevisiae* (yeast) and *Homo sapiens*, respectively, have been shown to play roles in promoting SSE between homologous sequences by binding to DNA and forming nucleoprotein filaments ([@B6], [@B7]). Previously, our lab has shown that PfRad51, the homologue of Rad51 in *P. falciparum*, exhibited ATPase activity, promoted DNA SSE *in vitro* ([@B8]), and may play a functional role(s) during HR, rearrangements, and DNA damage repair.

Another key player in HR is Rad54, a member of the Swi2/Snf2 subfamily of double-stranded DNA (dsDNA)-dependent ATPases ([@B9], [@B10]). Rad54 interacts with Rad51 and plays roles in multiple stages of HR ([@B11], [@B12]). A role for the Rad54 homologue in *P. falciparum* and its involvement in facilitating activities of PfRad51 are not known. Replication protein A (RPA), another molecular component involved in HR, is a heterotrimeric complex, vital for DNA replication, repair, and recombination ([@B13], [@B14]). RPA has been shown to consist of 70-kDa (RPA1), 32-kDa (RPA2), and 14-kDa (RPA3) subunits ([@B15]). Genes encoding RPA subunits have been identified and described in several protozoan parasites, such as *Cryptosporidium parvum* CpRPA1 ([@B16]), *Crithidia fasciculata* CfRPA1 ([@B17]), and *P. falciparum* PfRPA1 ([@B18]). RPA1 is present in two different forms in *C. parvum*, *Toxoplasma gondii*, and *P. falciparum*. The two open reading frames (ORFs) of the RPA1 gene in *P. falciparum* encode a truncated short RPA1S protein (PFI0235w; \~50 kDa) and a longer RPA1L protein (PFD0475c; \~134 kDa) ([@B18], [@B19]), differentially expressed across the parasite life cycle, indicating the different possible roles during parasite development ([@B19]). Although the biochemical functions of the RPA1 complex have been well detailed in humans and yeasts, their role in the malaria parasite is not known. Detailed biochemical characterization of the recombination proteins PfRad54 and PfRPA1 may provide further insights into DNA recombination and DNA damage repair mechanisms in these organisms.

In this study, we sought to characterize molecular components of the recombination machinery in *P. falciparum* to provide a mechanistic understanding of recombinational DNA rearrangement. We evaluated the catalytic functions of PfRad51 in the presence of the putative interacting partners PfRad54, PfRPA1L, and PfRPA1S and divalent cations. Our data indicate that a coordinated involvement of these proteins may play a functional role in HR and DNA repair mechanisms in the malaria parasite and may provide additional targets for the development of novel antimalaria drugs. A long-term significance of our studies lies in the potential to investigate recombinational rearrangement of the *var* genes involved in antigenic variation, one of the major impediments in generating protective immune responses against a wide array of genetically diverse malaria parasites.

RESULTS {#h1}
=======

Identification of homologues of the components of recombination machinery in *P*. *falciparum.* {#h1.1}
-----------------------------------------------------------------------------------------------

We have previously cloned and characterized PfRad51, a *P. falciparum* recombinase ([@B8]). Mining the *P. falciparum* genome database also revealed that Dmc1 (MAL8P1.76), MRE11 (PFA0390w), and Rad54 are involved in HR; however, Rad52, whose association with DSB has been shown to be a prerequisite for the recruitment of Rad51 protein ([@B20]), appears to be absent in *P. falciparum*. A lack of PfRad52 stressed that other interacting proteins must be influencing or regulating Rad51-mediated SSE reactions in *P. falciparum*. When the PfRad54 sequence was aligned with other eukaryotic Rad54 sequences, it revealed regions of considerable sequence similarity and dissimilarity, including gaps and insertions (see [Fig. S1](#figS1){ref-type="supplementary-material"} and S2 in the supplemental material). [Figure 1A](#fig1){ref-type="fig"} identifies the conservation of various functional domains in PfRad54; the N-terminal region is expected to contain a putative Rad51 interaction domain, and the functional significance of the C-terminal region in PfRad54 is unknown. The *P. falciparum* genome also encodes two RPA1 subunits (PFI0235w and PFD0475c), a single RPA2 subunit (chr11.phat_340), and a single RPA3 subunit (PF07_0039). The ORFs of the RPA1 subunits encode a truncated short PfRPA1S protein (\~50 kDa) and a longer PfRPA1L protein (\~134 kDa) ([@B18], [@B19]), compared to only a single molecule in higher eukaryotes ([Fig. S2](#figS2){ref-type="supplementary-material"}). PfRPA1L contains an extended N terminus ([Fig. 1B](#fig1){ref-type="fig"}) and a Zn finger motif in the N-terminal region lacking in PfRPA1S. Proteomics data (<http://www.plasmodb.org>) and a reported protein-DNA binding study ([@B18]) suggest that PfRPA1L and PfRPA1S bind to single-stranded DNA (ssDNA) with high affinity. None of the molecules involved in nonhomologous end joining (NHEJ) were revealed in the *Plasmodium* genome sequence.

![(A) Schematic representation of ScRad54 and PfRad54 proteins. Region A in ScRad54 has been shown to be important for interaction with Rad51 ([@B30]). Regions B and C constitute the catalytic core domain conserved in Rad54. (B) Schematic representation of PfRPA1L and PfRPA1S. The common region includes the ssDNA binding domain. The long form contains an N-terminal extension of unknown function. (C) Purity of purified recombinant PfRad51, PfRad54, PfRPA1L, and PfRPA1S after SDS-PAGE analysis and staining with Coomassie blue (lanes C) and after Western blot analysis using anti-6×His tag conjugate antibody (1:10,000) (lanes W). Numbers in parentheses indicate the molecular masses (kDa) of the purified proteins.](mbo0021315100001){#fig1}

Purification of recombinant His-tagged PfRad51, PfRad54 (1 to 164), PfRPA1L (678 to 1145), and PfRPA1S proteins. {#h1.2}
----------------------------------------------------------------------------------------------------------------

Recombinant PfRad51 was purified ([Fig. 1C](#fig1){ref-type="fig"}) as described previously ([@B8]). The amino-terminal region (amino acid residues 1 to 164) corresponding to putative PfRad51-interacting domain A of PfRad54, and the ssDNA binding domains of PfRPA1L and PfRPA1S were expressed as 6×His-tagged products and purified using Ni-nitrilotriacetic acid (NTA) beads ([Fig. 1A](#fig1){ref-type="fig"}). [Figure 1C](#fig1){ref-type="fig"} shows the purified PfRad54, PfRPA1L, and PfRPA1S proteins used in various functional assays. The size and purity were confirmed by Coomassie blue staining and Western blot analysis using anti-6×His tag conjugate antibody (Clontech Laboratories, Inc., CA), which recognizes His tag expressed in all the recombinant proteins.

The N*-*terminal domain of recombinant PfRad54 protein accelerates homologous DNA SSE in the presence of recombinant PfRad51 and CaCl~2~. {#h1.3}
-----------------------------------------------------------------------------------------------------------------------------------------

The role of Rad54, a protein that belongs to the core enzymatic machinery of HR in eukaryotes, has been shown to stimulate the SSE activity of Rad51 ([@B21]). In order to establish a functional role for Rad54 in the malaria parasite, we purified the N-terminal region of PfRad54 (amino acids \[aa\] 1 to 164) and evaluated its participation in SSE catalyzed by PfRad51. Linear dsDNA (øX 174) and homologous circular øX 174 ssDNA substrates were incubated in the presence of ATP, MgCl~2~, PfRad51, and single-stranded binding protein (SSB), as previously reported ([@B8]). PfRad51-mediated SSE was noticeable at the 15-min ([Fig. 2B](#fig2){ref-type="fig"}, panel I) time point. We next supplemented the SSE reaction with purified PfRad54 (2 µM) in the presence or absence of CaCl~2~. The kinetics of PfRad51-catalyzed SSE with or without PfRad54 were comparable ([Fig. 2B](#fig2){ref-type="fig"}, panel II); however, the presence of 0.5 mM CaCl~2~ and PfRad54 accelerated the formation of intermediate products from 15 min in the absence of CaCl~2~ to 10 min in the presence of CaCl~2~ ([Fig. 2B](#fig2){ref-type="fig"}, panel III; see also [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material). PfRad54 and CaCl~2~ in the absence of PfRad51 were not effective in the SSE (data not shown). This observation is in agreement with the idea that Ca^2+^ is a universal cofactor of DNA SSE promoted by mammalian homologous recombination proteins *in vitro* ([@B22]). These results also support that the PfRad54 region chosen for expression for functional studies is indeed capable of interacting with PfRad51 during SSE.

![(A) Schematic representation of the SSE assay. (B) Recombinant PfRad54 protein promotes pairing of homologous DNA in the presence of recombinant PfRad51 and CaCl~2~. (I) PfRad51 alone. (II) PfRad51 and PfRad54. (III) PfRad51, PfRad54, and 0.5 mM CaCl~2~. Aliquots were collected at time points (min) indicated above each lane and quenched with stop solution, and products were revealed on 1% TAE agarose gel, followed by ethidium bromide staining. Lds, linear double-stranded DNA; NC, nicked circular dsDNA; JM, joint molecule. The figure is a representative assay of three biologically independent strand exchange assays.](mbo0021315100002){#fig2}

Recombinant PfRPA1L serves the function of SSB, whereas recombinant PfRPA1S does not exhibit any SSB-like function. {#h1.4}
-------------------------------------------------------------------------------------------------------------------

To test the function of the two RPA1 subunits in SSE in *Plasmodium*, we performed the SSE using PfRPA1L instead of SSB. As shown in [Fig. 3A](#fig3){ref-type="fig"} (panel II), when PfRPA1L was used in place of SSB, PfRPA1L was able to efficiently initiate SSE catalyzed by PfRad51. The kinetics of this reaction was found to be similar to that of SSB, and the intermediate products were visible at the 15-min time point of the reaction ([Fig. 3A](#fig3){ref-type="fig"}, panels I and II). On the other hand, PfRPA1S did not initiate a SSE reaction, even after 45 min of the reaction ([Fig. 3A](#fig3){ref-type="fig"}, panel III). These results suggest that PfRPA1L exhibits an SSB-like function in SSE initiation whereas PfRPA1S does not exhibit any such function.

![(A) Role of PfRPA1L and PfRPA1S during SSE activity of PfRad51. (I) PfRad51 and SSB. (II) PfRad51 and PfRPA1L. (III) PfRad51 and PfRPA1S. (B) PfRPA1S downregulates the function of PfRPA1L. (I) PfRad51, 0.5 μM PfRPA1L, and 0.5 μM PfRPA1S. (II) PfRad51, 0.5 μM PfRPA1L, and 0.75 μM PfRPA1S. (III) PfRad51, 0.5 μM PfRPA1L, and 1.0 μM PfRPA1S. (IV) PfRad51, 0.5 μM PfRPA1L, and 2.0 μM PfRPA1S. (V) PfRad51 and 0.5 μM PfRPA1S preincubated for 10 min, followed by addition of 0.5 μM PfRPA1L. (VI) PfRad51 and 0.5 μM PfRPA1S preincubated for 10 min, followed by addition of 1.0 μM of PfRPA1L. (C) Role of PfRad51, PfRPA1L, and PfRPA1S in the presence of the bacterial homologue RecA and SSB. (I) PfRad51, 0.5 μM SSB, and 0.5 μM PfRPA1S. (II) RecA and PfRPA1L. (III) RecA and PfRPA1S. (IV) RecA, 0.5 μM PfRPA1L, and 0.5 μM PfRPA1S. Aliquots were collected at time points (min) indicated above each lane and quenched with stop solution, and products were revealed on 1% TAE agarose gel, followed by EtBr staining. Lds, linear double-stranded DNA; NC, nicked circular dsDNA; JM, joint molecule. These figures are a representative assay of three biologically independent strand exchange assays.](mbo0021315100003){#fig3}

PfRPA1S downregulates the function of PfRPA1L but not SSB. {#h1.5}
----------------------------------------------------------

Intrigued by the presence of two molecular forms of RPA1 in *P. falciparum*, we performed SSE assays in the presence of both PfRPA1L and PfRPA1S. When equal molar amounts of PfRPA1L and PfRPA1S (0.5 µM) were added to initiate the reaction, there was a delay in the reaction initiation (from 15 min to 30 min) ([Fig. 3B](#fig3){ref-type="fig"}, panel I). A further increase in the PfRPA1S concentration to 1 µM (2-fold molar excess over PfRPA1L) deferred the reaction from 30 min to 60 min ([Fig. 3B](#fig3){ref-type="fig"}, panel III), and no intermediate products were seen even 120 min after reaction initiation when PfRPA1S was increased to 2 µM (4-fold molar excess over PfRPA1L) ([Fig. 3B](#fig3){ref-type="fig"}, panel IV). This inhibitory activity of PfRPA1S was observed even if SSE was carried out in the presence of PfRad54 and 0.5 mM CaCl~2~ (data not shown).

In view of the negative regulation of PfRPA1L by PfRPA1S, we also investigated whether or not the order in which these two were added to initiate the reaction would influence the outcome. The reaction was first initiated with PfRPA1S (0.5 µM) for 10 min, followed by addition of PfRPA1L (0.5 µM). The SSE was delayed to 30 min as previously seen ([Fig. 3B](#fig3){ref-type="fig"}, panel V) when the two were added simultaneously. The negative effect of 0.5 µM PfRPA1S was nullified if the amount of PfRPA1L was doubled to 1 µM instead of the standard 0.5 µM ([Fig. 3B](#fig3){ref-type="fig"}, panel VI), suggesting titrability of negative regulatory activity of PfRPA1S by PfRPA1L.

Recombinant PfRPA1L can initiate SSE in the presence of both PfRad51 and the bacterial homologue RecA. {#h1.6}
------------------------------------------------------------------------------------------------------

To further test whether the inhibition of SSE by PfRPA1S was a generalized effect or specific to PfRPA1L, we incubated equal amounts of SSB and PfRPA1S (0.5 µM) to initiate the reaction. As seen in [Fig. 3C](#fig3){ref-type="fig"}, panel I, there was no delay in the reaction by PfRPA1S carried out in the presence of SSB, suggesting that PfRPA1S specifically slows down or inhibits the activity of PfRPA1L. To further characterize the SSB-like function of PfRPA1L, we compared SSE activity initiated by RecA. As shown in [Fig. 3C](#fig3){ref-type="fig"}, panel II, PfRPA1L can facilitate RecA-mediated SSE as efficiently as SSB, further suggesting that PfRPA1L is indeed a functional homologue of SSB in *P. falciparum*. Not surprisingly, PfRPA1S was not active in the presence of RecA, as there were no intermediate products formed even after 60 min ([Fig. 3C](#fig3){ref-type="fig"}, panel III). When PfRPA1L and PfRPA1S were incubated together in the presence of RecA, PfRPA1S again deferred the reaction initiated by PfRPA1L from 10 min to 20 min ([Fig. 3C](#fig3){ref-type="fig"}, panel IV), suggesting that PfRPA1S specifically interacts with and delays the reaction facilitated by PfRPA1L regardless of the recombinase used (RecA or PfRad51).

Induction of various recombination molecules in the parasites in response to the DNA-damaging agent MMS. (i) Transcriptional effects. {#h1.7}
-------------------------------------------------------------------------------------------------------------------------------------

Exposure to the DNA-alkylating agent methyl methane sulfonate (MMS) has been shown to lead to overexpression of *rad51* ([@B23]--[@B25]), *rad54* ([@B26]--[@B28]), and *rpa1* ([@B29], [@B30]). These studies also showed that mutation of the above-mentioned genes made the cells sensitive to MMS, indicating their roles in DNA repair. Previously, we have shown that *Plasmodium* Rad51 is upregulated in response to DNA damage created by MMS. We then studied MMS-induced changes in the expression of PfRad54 and PfRPA1 (long \[L\] and short \[S\] forms) initially by reverse transcription-PCR (RT-PCR) (data not shown), followed by quantitative real-time PCR. [Figure 4A](#fig4){ref-type="fig"} shows relative quantification measured by the Pfaffl method ([@B31]) and the average threshold cycle (∆∆*C*~*T*~) value of each gene across the different erythrocytic stages (rings, trophozoites, and schizonts). The average ∆∆*C*~*T*~ values for induced PfRad51 and PfRad54 in the ring and trophozoite stages of *P. falciparum* were 2 to 2.5 times higher than those in uninduced parasites. However, the highest fold induction detected was 11 to 30 times in the schizont stages. The transcriptional changes for *pfrpa1L* and *pfrpa1S* were also 10 to 100 times higher than those for control samples, suggesting that genes for both S and L forms of RPA1 are also induced during MMS treatment. This finding suggests coregulation and functional involvement of both RPA1L and RPA1S during the DNA damage repair process in the malaria parasites. The *P* values were corrected using the Bonferroni method, and *P* values of the various samples were \<0.0001 to 0.0016, suggesting that there was a statistically significant difference between the uninduced and MMS-induced samples across the erythrocytic cycle for all four genes tested, indicating the functional significance of these genes in the parasites undergoing active DNA replication. To rule out any genomic DNA (gDNA) contamination in any of the samples, the uninduced and induced samples were amplified with or without a reverse transcription step as well as using primers for a housekeeping stress-related gene, *Pfgrp78* ([@B32]). Equal amounts of total RNA from control and MMS-treated parasites were used in these studies. Transcripts (amplified 434-bp product) for *Pfgrp78* were of comparable intensities in uninduced and induced samples in the life cycle stages of the parasite (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material). These primers also amplify a 289-bp-larger band from genomic DNA templates due to the presence of an intron, and these results rule out any genomic DNA contamination in the RNA preparations. Likewise, no PCR products were seen when the reverse transcription step was omitted ([Fig. S5](#figS5){ref-type="supplementary-material"}).

![Induction of recombination molecules by MMS. (A) Transcriptional changes upon MMS treatment, analyzed by real-time RT-PCR. Parasite cultures were synchronized by the sorbitol method, and cDNA was synthesized from purified RNA from rings, trophozoites, and schizonts. Untreated and 0.05% and 0.005% MMS-treated samples from each stage were collected for analysis. cDNA was then amplified by PCR using gene-specific primers (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material) using the Bio-Rad IQ5 real-time PCR detection system. *P. falciparum* seryl tRNA synthetase was used as an internal control gene. All *P* values lie between \<0.0001 and 0.0016. The error bars represent the standard error of the mean (SEM). (B) Recognition of purified recombinant proteins by anti-PfRad51 and anti-ScRad54 sera. Recombinant proteins were run on 10% SDS-PAGE gel, transferred to nitrocellulose membrane, and probed with immune (lanes 2) and preimmune (lanes 1) sera, followed by ECL detection. (C) MMS induced expression of PfRad51 (top) and PfRad54 (middle) proteins. Western blot analysis of PfRad51 and PfRad54 proteins following MMS treatment of *P. falciparum*. U, uninduced sample; lanes 1 and 2, induced with 0.005% and 0.05% MMS, respectively, from ring-, trophozoite-, and schizont-stage *P. falciparum* cultures. The lower panel serves as a loading control showing comparable expression of PfHSP70 protein (75 kDa) in uninduced and induced parasites from each stage.](mbo0021315100004){#fig4}

(ii) Translational effects. {#h1.8}
---------------------------

Western blot analysis was carried out to further demonstrate that MMS induction was seen at the protein level as well. Previously, our lab has shown that MMS treatment resulted in the induction of PfRad51 expression ([@B33]). We treated synchronized ring-, trophozoite-, and schizont-stage parasites for 6 h with 0.05% and 0.005% MMS. The expression of PfRad54 was assessed using the ScRad54 antibody (a generous gift from Wolf-Dietrich Heyer, UC, Davis), which recognizes recombinant truncated PfRad54 expressed in *E. coli* (23 kDa) ([Fig. 4B](#fig4){ref-type="fig"}, lane 2) and full-length PfRad54 (140 kDa) in the *P. falciparum* lysates. Pooled preimmune serum (negative controls) did not recognize any proteins in the parasite lysates ([Fig. 4B](#fig4){ref-type="fig"}, lane 1). Three independent experiments were performed, and [Fig. 4C](#fig4){ref-type="fig"} shows results of one such typical experiment. Treatment with 0.05% and 0.005% MMS showed a marked induction in PfRad51 and PfRad54 expression ([Fig. 4C](#fig4){ref-type="fig"}). These results demonstrate that the expression of both PfRad51 and PfRad54 is upregulated in response to exposure to a DNA-damaging agent, thereby strongly suggesting a conserved role for PfRad54, just like PfRad51 in the recombinational repair process. Similar Western blot analysis for RPA1 (L and S forms) could not be performed due to nonavailability of specific antibodies.

(iii) Evidence for DNA damage by MMS and DNA repair in malaria parasites. {#h1.9}
-------------------------------------------------------------------------

MMS is a known DNA-damaging agent and has been shown to induce PfRad51 ([@B33]). We wanted to establish that such induction of recombination molecules in *P. falciparum* is indeed in response to actual DNA damage caused by MMS in the parasite. To visualize and quantify DNA damage, we performed Comet assays and analyzed DNA damage in individual cells. The shapes of the DNA comet tail and migration pattern were evaluated to assess the extent of DNA damage. As seen in [Fig. 5A](#fig5){ref-type="fig"}, maximum comets were seen in the MMS-treated schizont stage (average Olive tail moment \[OTM\], 18.1) compared to rings (1.5) and trophozoites (11.8). In order to establish a functional DNA repair process in *P. falciparum*, we then assessed the ability of these parasites to repair damaged DNA in a "return-to-growth" experiment. [Figure 5B](#fig5){ref-type="fig"} illustrates a correlation between the Olive tail moment (the product of the proportion of tail intensity and the displacement of tail center of mass relative to the center of the head) and the parasitemia over various time points during the return-to-growth phase. Parasite growth was restored to normal levels in MMS-treated samples after 42 h, and it was comparable to that of control samples (mock treated) maintained in parallel. The comet OTM (with a larger value indicating DNA damage) was inversely proportional to parasitemia, as parasites repaired damaged DNA and returned to normal growth. Starting from a value of 56.1 immediately after MMS treatment, the OTM values decreased to 41.3 at 12 h, 21.6 at 18 h, and 2.6 at 42 h, providing evidence for the presence of DNA damage during the first 18 h followed by repair of DNA damage and restoration of parasite growth by 42 h ([Fig. 5C and D](#fig5){ref-type="fig"}). To further establish a relationship between parasite growth and DNA repair within the damaged cells, Comet assay data were further analyzed to assess the percentage of nuclei with damaged DNA. The scoring included the total number of nuclei, the number of intact heads (undamaged), and the number of comets (damaged), and the percentages of damaged and undamaged nuclei were calculated before (0 h) and 6 h after MMS treatment as well as at 12, 18, and 42 h during the back-to-growth condition. In parallel, control samples (mock treatment) were also analyzed at the indicated time points. As seen in [Fig. 5C and D](#fig5){ref-type="fig"}, as the parasite growth recovered, it was accompanied by repair of damaged DNA, indicated by an increase in the percentage of intact undamaged nuclei and a gradual decrease in the OTM values. Spearman's rank correlation analysis revealed a rho value of −0.96, indicating a negative correlation between OTM and percent parasite growth recovery. These studies provide experimental evidence for MMS-induced DNA damage in the parasite and the involvement of functional DNA repair mechanisms in response to DNA damage.

![Evidence for DNA damage and DNA repair. (A) Comet assay visualization of the DNA damage in the parasites upon treatment with 0.05% MMS in different erythrocytic stages of *P. falciparum*. (B) Parasite growth versus Comet assay olive tail moment at 6 h, 12 h, 18 h, and 42 h after MMS (0.05%) treatment compared to untreated parasites. The error bars represent the SEM. Parasitemia differences between the MMS-treated and control samples were not statistically significant. (C) Parasite recovery versus Comet assay olive tail moment. Comet assay data were analyzed to score damaged and undamaged nuclei for each sample. Shown are Comet assay results indicating DNA repair through percent recovery in MMS-treated and control parasites at 12 h, 18 h, and 42 h of the recovery period. The majority of parasites (97%) were recovered at 18 h, with only 3% of parasites exhibiting a high OTM value (21.6). The error bars represent the SEM. (D) Parasite recovery visualization by Comet assay at 12 h, 18 h, and 42 h (no visually detectable tail) during the return to growth after MMS treatment.](mbo0021315100005){#fig5}

DISCUSSION {#h2}
==========

In this study, we have provided new insights into the role of the interacting partners of Rad51, Rad54, and RPA and their involvement in HR and DNA repair in *P. falciparum*. Failure to identify homologues of PfRad52 and the accessory proteins PfRad55 and PfRad57 by genome mining and the presence of two RPAs distinct from those of other higher eukaryotic cells suggest that DNA repair mechanisms in *Plasmodium* have evolved to retain functional similarities as well as unique features compared to other species. Previously, we have shown that Rad51 participates in HR mechanisms in the apicomplexan parasite *P. falciparum*. Rad51 has been shown to be present in other parasites: *Leishmania* Rad51 (LmRad51) and *Entamoeba histolytica* Rad51 (EhRad51) have been shown to bind to DNA and exhibit DNA-stimulated ATPase activity ([@B34], [@B35]), and *Trypanosome* Rad51 has been suggested to play a regulatory role in variant surface glycoprotein (VSG) switching ([@B36]). In other species, Rad54 and Rad51 form a complex nucleoprotein filament which stimulates Rad51, leading to translocation of target DNA to the site of homology search ([@B37], [@B38]). The absence of Rad52 and accessory proteins emphasizes the importance of the functional role of PfRad54 in facilitating PfRad51-mediated recombination and DNA repair. Unlike PfRad51, PfRad54 did not initiate SSE by itself; rather, it accelerated the reaction when combined with PfRad51 and Ca^2+^. Deletion analysis has shown that the Rad54 N-terminal domain is chiefly accountable for interactions with Rad51 ([@B39]) and thereby plays a key role in the function of the protein. We therefore focused our initial attempts on the N-terminal domain of PfRad54, a region homologous to ScRad54 which interacts with ScRad51, to study its role in SSE. Due to its large size (153 kDa), we did not attempt to express full-length PfRad54, which would have also included the DNA binding domain. We are not sure if this might account for the lack of SSE activity of PfRad54 alone.

The recruitment of Rad51 and Rad54 to the site of HR depends solely on the mode of action of single-stranded binding proteins (SSB), replication proteins (RPA eukaryotic homologues), and the DNA repair protein Rad52, all of which bind and stabilize single-stranded DNA (ssDNA). The *P. falciparum* genome encodes two RPA1 subunits (<http://www.plasmodb.org>), PfRPA1L and PfRPA1S, expressed differentially across the parasite life cycle, suggesting different possible roles of these subunits during parasite development ([@B19]). The absence of the Rad52 homologue in *P. falciparum* also suggests the importance of PfRPA1 proteins in engaging PfRad51 and PfRad54 at the site of recombination. Our results demonstrated an SSB-like function for PfRPA1L, whereas the role of PfRPA1S remains intriguing. PfRPA1S alone did not exhibit any SSE activity, and importantly, it resulted in a concentration-dependent inhibition of the activity of PfRPA1L, suggesting that PfRPA1S may be a regulator for PfRPA1L and SSE activity in *P. falciparum*. Considering that a Rad52 homologue is absent in *Plasmodium* and RPA1S does not exhibit SSE activity, the role of PfRPA1L becomes more critical in initiating SSE via removal of secondary structures from ssDNA. The observation that PfRPA1S specifically delayed or inhibited the reaction of PfRPA1L and not the bacterial homologue SSB further indicates that PfRPA1S likely interacts with PfRPA1L directly. These findings are significant, keeping in mind that Rad52 recruits Rad51, which interacts with ssDNA by displacing RPA ([@B40], [@B41]). In the absence of Rad52 in *Plasmodium*, we speculate that, depending upon the stoichiometry of available RPA1S and RPA1L, an interaction between RPA1S and RPA1L acts to limit the recruitment of PfRad51 to DNA and, hence, reduced SSE. We do not know if PfRPA1S prevents PfRad51 from binding to ssDNA or interacts with PfRPA1L directly and modulates its function. Since PfRPA1S is upregulated at the transcriptional level in response to a DNA-damaging agent, it is expected to participate in DNA damage repair and may even play an important role at a DNA damage checkpoint. We are investigating the biochemical nature and stoichiometry of this interaction, suggested by our studies to be an important regulator in *Plasmodium* HR and DNA damage repair.

In response to a serious threat like DNA damage, cells are endowed with an elaborate battery of DNA repair machinery that is triggered by unrepaired DSBs. In *Trypanosoma* and *Leishmania*, Rad51 has been shown to play a critical role in DNA repair pathways ([@B34], [@B36]). Previously, our lab has presented evidence for induction of PfRad51 in response to the DNA-damaging agent MMS ([@B33]), suggesting a conserved role for this gene in recombinational repair processes in the protozoan parasites. Results now presented in the current study demonstrate that in addition to the induction of PfRad51, expression of PfRad54, PfRPA1L, and PfRPA1S was significantly upregulated in response to MMS. Since maximum response was seen in the mitotically active trophozoites and schizonts, it also suggests a link between the activity of recombination molecules and DNA replication.

In addition, we have also shown that MMS does indeed cause DNA damage in *P. falciparum*. Using a Comet assay, we observed maximum values for comet tails in the schizont stage ([Fig. 5A](#fig5){ref-type="fig"}) that are undergoing DNA replication. In order to establish a functional DNA repair process in *P. falciparum*, we performed return-to-growth experiments. Further evidence for functional DNA repair in response to DNA damage through analysis of recovery of parasites in culture and reversal of DNA damage was revealed by comet tail shortening. Both parasite growth and MMS-induced DNA damage returned to normal values within 24 to 42 h of the recovery phase.

Results of the studies presented suggest a role for Rad51, Rad54, RPA1L, and RPA1S in DNA repair and DNA recombination. One point of regulation may be exerted at the level of PfRPA1S. PfRPA1S was found to negatively regulate the function of PfRPA1L, and during MMS-induced DNA damage, expression of both PfRPA1L and PfRPA1S was markedly upregulated. Further studies are needed to define these molecular interactions. Our current observations allow us to speculate the following possible roles of PfRPA1S, which are represented in [Fig. S6](#figS6){ref-type="supplementary-material"} in the supplemental material. In the absence of PfRPA1S, PfRPA1L efficiently initiates SSE catalyzed by PfRad51 and, hence, serves the function of SSB ([Fig. S6A](#figS6){ref-type="supplementary-material"}). When PfRPA1S is also present, it likely interacts with PfRPA1L either directly or through yet-unknown mediators or cofactors and slows down the SSE, delaying product formation ([Fig. S6B](#figS6){ref-type="supplementary-material"}). In the presence of \>4-fold molar excess of PfRPA1S compared to PfRPA1L, no SSE occurs, indicating the titrability of PfRPA1L by the negative regulatory activity exerted by PfRPA1S ([Fig. S6C](#figS6){ref-type="supplementary-material"}). The nature of the interaction of these macromolecular complexes in the parasites through various life cycle stages is currently under investigation. Since the short form of RPA1 is present in a few other apicomplexan parasites, e.g., *Cryptosporidium* and *Toxoplasma*, our studies with PfRPA1S may provide an excellent model system to study DNA damage and repair as well as a potential checkpoint in HR and DNA repair in these medically important apicomplexan parasites and other biological systems in which multiple forms of RPA1 are present.

MATERIALS AND METHODS {#h3}
=====================

Cloning, expression, and purification of recombinant PfRad51, PfRad54, PfRPA1L, and PfRPA1S. {#h3.1}
--------------------------------------------------------------------------------------------

Recombinant PfRad51 was purified as described previously ([@B8]). The N-terminal (putative Rad51 interacting domain) coding sequence of PfRad54 (GeneID Pf08_0126; bp 1 to 492 of the coding sequence) was cloned into the expression vector pRsetA (Invitrogen), giving rise to a product containing a 6-histidine tag at the N terminus of the expressed protein, referred to throughout as PfRad54. After verifying the sequence, the plasmid was transfected in *Escherichia coli* host strain BL21\* (DE3)-pLys S (Invitrogen). Gene-specific oligonucleotides used for amplification are shown in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. Cultures were grown at 37°C in Luria broth containing 50 µg/ml ampicillin to an optical density at 600 nm (OD~600~) of 0.6. Expression of recombinant protein was induced by IPTG (isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside) (1 mM), and incubation continued for 3 h. Cells were harvested and resuspended in 5 ml of lysis buffer (50 mM phosphate buffer, pH 8, 300 mM NaCl, 10 mM imidazole, 0.1% lysozyme) per gram of bacterial pellet, incubated on ice for 30 min, and lysed by sonication (3 bursts of 1-min pulse at 4°C). The lysate was centrifuged at 17,500 × *g* for 30 min, and the pellet was resuspended in 100 ml of 100 mM Tris, pH 7.5, and 4 M urea, stirred at 4°C for 30 min, and centrifuged at 17,500 × *g*. The supernatant was loaded over a Ni-NTA agarose column (Qiagen) and washed with phosphate buffer (50 mM, pH 8) containing 20 mM imidazole, and bound protein was eluted with elution buffers (25 mM Tris-HCl, pH 7.5, 100 mM NaCl) containing increasing amounts of imidazole (50, 100, 150, or 200 mM). The 200 mM imidazole elution fractions containing recombinant proteins were pooled and dialyzed against the dialysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM dithiothreitol \[DTT\], 1 mM EDTA, 10% glycerol) to remove imidazole. The purified protein was tested by Coomassie blue staining and Western blot analysis using antibody specific for the 6×His tag. The protein concentration was measured by the bicinchoninic acid (BCA) method and stored at −80°C until further use.

The 3′ end of the PfRPA1L gene (GeneID PfD0470c; bp 2035 to 3438 of the coding sequence, referred as PfRPA1L) and the full coding sequence of the PfRPA1S gene (GeneID PFI0235w; bp 1 to 1455) were each cloned into the expression vector pRsetA. Gene-specific oligonucleotides used for amplification are shown in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. Cultures were grown at 30°C in Luria broth containing 50 µg/ml ampicillin to an OD~600~ of 0.6. Expression of recombinant protein was induced by IPTG (0.5 mM), and incubation continued for 2 h at 25°C. Cells were harvested and resuspended in 5 ml of lysis buffer (25 mM Tris, pH 7.5, 1 mM EDTA, 5% glycerol, 100 mM NaCl, 0.1% lysozyme) per gram of bacterial pellet. The cultures were incubated on ice for 30 min and lysed by sonication (3 bursts of 1-min pulse at 4°C). The lysate was then centrifuged at 17,500 × *g* for 20 min, and the supernatant was loaded over a Ni-NTA-agarose column after column equilibration with 25 mM Tris, pH 7.5, 5% glycerol, 1 mM DTT, 100 mM NaCl, and 10 mM imidazole. The column was washed with 25 column volumes of wash buffer (25 mM Tris, pH 7.5, 5% glycerol, 1 mM DTT, 100 mM NaCl, 20 mM imidazole), and bound protein was eluted with elution buffers (25 mM Tris-HCl, pH 7.5, 100 mM NaCl) containing increasing amounts of imidazole (50, 100, 150, 200, and 250 mM). The 250 mM imidazole elution fractions were pooled and dialyzed against the dialysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, 10% glycerol) to remove imidazole. The purified protein was tested by Coomassie blue staining and Western blot analysis using antibody specific for the 6×His tag. The protein concentration was measured by the BCA method and stored at −70°C until further use.

Single-stranded exchange assay. {#h3.2}
-------------------------------

The assay mixture contained reaction buffer (25 mM Tris-HCl, pH 7.5, and 5% glycerol), 10 mM MgCl~2~, 5 µM circular ΦX 174 RF I dsDNA (New England Biolabs \[NEB\]), 15 µM ΦX virion dsDNA (NEB), 1 mM DTT, and 2 µM concentrations of the proteins (RecA obtained from NEB M0249S, PfRad51, or PfRad54) to be tested for functional activity. The reaction mixture (135 µl) was preincubated at 37°C for 10 min, followed by addition of 15 µl of an initiation mixture (final concentration of 25 mM Tri-HCl, pH 7.5, 5% glycerol, 3 mM ATP, and 0.5 µM single-stranded binding protein \[SSB from Stratagene or PfRPA1L or PfRPA1S\]). Aliquots were collected at indicated time points and quenched with stop solution (1% SDS, 15 mM EDTA), and the products were analyzed by 1% Tris-acetate-EDTA (TAE) agarose gel electrophoresis. The gel was run overnight at 18V, stained for 1 h with ethidium bromide (final concentration, 0.5 μg/ml), and visualized after destaining in water.

Parasite culture, RNA extraction, and cDNA synthesis. {#h3.3}
-----------------------------------------------------

*P. falciparum* clone 3D7 was grown at 4% hematocrit in RPMI 1640 medium supplemented with 10% O^+^ normal human serum and red blood cells. Parasites were cultured at 37°C using the candle jar method ([@B42]) and visualized by Giemsa stain ([@B43]). Parasite cultures were synchronized by the sorbitol method as described previously ([@B44]). Synchronized ring-, trophozoite-, and schizont-stage parasites were treated with 0.005% and 0.05% methyl methane sulfonate (MMS) in the culture medium at 37°C, and aliquots were collected for RT-PCR and Western blot analysis. RNA was extracted from MMS-treated and untreated parasites using Trizol reagent (Invitrogen), and the concentration of RNA was measured using NanoDrop (model 2000/2000c). One microgram of RNA was reverse transcribed using oligo(dT)~18~ primer, a first-strand cDNA synthesis kit (Roche Diagnostics GmbH), and cycler protocol conditions as described by the manufacturer. The resulting cDNAs were subjected to PCR amplification for 30 cycles using gene-specific primers. Control reactions without reverse transcriptase were carried out to confirm that no DNA contamination was present in the RNA samples. The products were run on 1% agarose gel and stained with ethidium bromide.

Western blot analysis. {#h3.4}
----------------------

MMS-treated synchronized parasites were released from red cells by 0.01% saponin lysis for 5 min at 0°C and washed two times in ice-cold phosphate-buffered saline (PBS). The samples were analyzed by Western blotting using a 1:5,000 dilution of mouse anti-PfRad51 (M. Bhattacharyya and N. Kumar, unpublished data), a 1:5,000 dilution of mouse anti-ScRad54 (a kind gift from Wolf-Dietrich Heyer, UC, Davis), and a 1:7,500 dilution of mouse anti-PfHsp70 ([@B45]) antibody using enhanced chemiluminescence (ECL)-based detection methods (Amersham Pharmacia Biotech).

Comet assays and DNA damage repair. {#h3.5}
-----------------------------------

MMS-treated synchronized parasites corresponding to 4 × 10^5^ infected red blood cells were collected, lysed with 0.01% saponin, washed three times with cold PBS, and finally resuspended in 1.0 ml PBS for single-cell gel electrophoresis (Comet assays) ([@B46]). Diluted cells (30 µl) were mixed with 300 µl Comet LMAgarose (1% low-temperature melting agarose \[Trevigen, Gaithersburg, MD\]), and the mixture was added to wells of a Trevigen slide, incubated at 4°C for 30 min, and immersed in chilled lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris base, 1% *N*-lauryl-sarcosine, 1% Triton X-100) at 4°C for 60 min. Excess lysis solution was removed from slides and then transferred to a clean tray immersed in alkaline lysis solution (200 mM NaOH and 1 mM EDTA), rinsed for 5 min in 1× Tris-borate-EDTA (TBE), and electrophoresed for 10 min at 1 volt/cm in 1× TBE. Slides were fixed in 70% ethanol and dried overnight. Wells were stained with 50 µl freshly prepared SYBR green I and photographed at ×200 magnification using a Nikon Eclipse 80i (Nikon) with a Sensicam QE high-performance camera (Cooke Corporation). Comets were scored for all samples using Comet assay IV software. Control parasites exposed to a 5-Gy dose of radiation (cesium 137; Gammacell-40 by NordIon International) were used to guide Comet assay software (Trevigen, Gaithersburg, MD) for quantitation of DNA damage. An automatic scoring method measured comet head and tail lengths, head and tail percent intensity, tail migration, and Olive tail moment (OTM) (the product of the tail length and the fraction of total DNA in the tail). To study the efficiency of the DNA damage repair process in *P. falciparum*, parasites were treated with 0.05% MMS (6 h at 37°C), washed, and recultured in the presence of fresh growth medium and uninfected erythrocytes for 42 h. Cultures were harvested at various intervals (12, 18, and 42 h) to prepare blood smears to check parasite growth and DNA damage by Comet assays. For each sample (control and MMS treatment) and each time point, three replicates were performed and an average of their OTM values was used for data analysis.

Real-time quantitative PCR. {#h3.6}
---------------------------

RNA preparation and cDNA synthesis details were as explained above. Quantitative PCR (qPCR) samples were prepared in IQ SYBR green Supermix containing SYBR green dye, iTaq DNA polymerase, deoxynucleoside triphosphates (dNTPs), and buffers (Bio-Rad), 0.4 µM concentrations of each oligonucleotide primer (see [Table S2](#tabS2){ref-type="supplementary-material"} in the supplemental material), and a 1:100 dilution of the cDNA reaction. Amplification was performed on a Bio-Rad IQ5 real-time PCR detection system using 95°C for 2 min for initial denaturation and enzyme activation, followed by a further incubation at 95°C for 3 min and 45 cycles of 95°C for 30 s, 50°C for 30 s, and 72°C for 30 s. *P. falciparum* seryl tRNA synthetase (GeneID PF07_0073) was used as an internal control gene. A set of three independent replicates was obtained, and the average value from that was taken for data analysis.

Data analysis and statistical evaluation. {#h3.7}
-----------------------------------------

Relative *C*~*T*~ values from real-time RT-PCR in the induced and uninduced samples were calculated by using the Pfaffl method ([@B31]). Briefly, the average *C*~*T*~ value from three independent replicates of the internal control gene (seryl tRNA synthetase) was subtracted from the average *C*~*T*~ value for each sample (control or induced) to calculate the ∆*C*~*T*~. The ∆*C*~*T*~ for each sample was divided by the ∆*C*~*T*~ of the control (uninduced sample) to obtain the ∆∆*C*~*T*~. The inverse of ∆∆*C*~*T*~ raised to the power of two determines the initial amount of DNA in each sample. The experimental standard deviation (SD) was calculated by the square root of the sum of the squares of the SD of each sample and the internal control. Finally, using the ∆*C*~*T*~ and the experimental SD, the induced sample was compared with the respective uninduced sample using InStat software (GraphPad) to calculate *P* values. The statistical adjustment for the multiple comparisons was accommodated by correcting the *P* value by the Bonferroni method.

SUPPLEMENTAL MATERIAL {#h4}
=====================
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Alignment of various domains (A, B, and C, represented in [Fig. 1A](#fig1){ref-type="fig"}) of PfRad54 with ScRad54 using BLAST analysis showing percent identity, positives, and *E* values. Download
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Figure S1, PDF file, 0.2 MB

###### 

Percent homology of the amino acid sequences of *Plasmodium* recombination molecules with those of yeast, human, *Leishmania*, *Trypanosome*, and *Cryptosporidium*. Percent homology of PfRPA1S is also shown with *Cryptosporidium* and *Toxoplasma*, the only other two apicomplexans that contain the short form of RPA1. PfRad51, a key molecule in homologous recombination, shows the highest homology with other species. Download
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Figure S2, PDF file, 0.3 MB
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\(A\) Role of CaCl~2~ (0.5 mM) in PfRad51-mediated SSE. (B) SSE showing various intermediate products when the gel was run for a shorter time period. Aliquots were collected at time points (min) indicated above each lane and quenched with stop solution, and products were revealed on 1% TAE agarose gel, followed by EtBr staining. Lds, linear double-stranded DNA; Css, circular single-stranded DNA; Lss, linear single-stranded DNA; NC, nicked DNA; JM, joint molecule. Download
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Figure S3, PDF file, 0.1 MB

###### 

Reverse transcriptase-PCR of *pfgrp*. Parasite cultures used for MMS induction studies for real-time PCR (results in [Fig. 5](#fig5){ref-type="fig"}) were independently verified for the absence of any trace of contaminating gDNA. Cultures were synchronized by sorbitol treatment, and cDNA was synthesized using total RNA purified from rings (lanes 1 to 3), trophozoites (lanes 4 to 6), and schizonts (lanes 7 to 9). Uninduced samples from each stage (lanes 1, 4, and 7) and 0.05% (lanes 2, 5, and 8) and 0.005% (lanes 3, 6, and 9) MMS-induced samples were collected for analysis. cDNA was amplified by PCR using *grp* gene-specific primers spanning the 5′ end of the gene spanning an intron and separated on 1% agarose gels. Lane 10 serves as the gDNA control to show the difference in size between cDNA and gDNA due to the presence of an intron (289 bp). The arrow on the right indicates the 723-bp size of the PCR product from gDNA, and the one on the left indicates the 434-bp size of the PCR product with cDNA. Download
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Figure S4, PDF file, 0.2 MB

###### 

Reverse transcriptase-PCR analysis in the presence and absence of RT for *pfrad51*. Parasite cultures were synchronized by sorbitol treatment, and cDNA was synthesized using RNA from MMS-induced (0.05%) rings, trophozoites, and schizonts (lanes 1). In parallel, samples from 0.05% MMS-treated samples were processed in the absence of reverse transcriptase to test for gDNA contamination (lanes 2). cDNA was then amplified by PCR using gene-specific primers and analyzed on 1% agarose gels. Download
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Figure S5, PDF file, 0.1 MB

###### 

PfRPA1S negatively impacts the function of PfRPA1L. (A) In the absence of PfRPA1S, PfRPA1L serves the function of SSB and PfRad51-mediated SSE is catalyzed. (B) Addition of PfRPA1S reduces PfRad51-mediated SSE. (C) Excess of PfRPA1S negatively impacts the function of PfRPA1L, and no SSE occurs. Download
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Figure S6, PDF file, 0.1 MB
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Nucleotide sequences of primers used for gene-specific amplification for expression. Engineered restriction enzyme sites (underlined) were added to each primer to facilitate directional cloning into the pRsetA vector.
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Table S1, PDF file, 0.1 MB.
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Nucleotide sequences of primers used for real-time PCR analysis.
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Table S2, PDF file, 0.1 MB.
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